SUPN

Supernus Pharmaceuticals Inc

2 super-investor ownerscombined $85Mlargest position 1.3%

2 super-investors hold SUPN worth a combined $85M. The largest position: Third Avenue Management at 1.3% of their portfolio. No cohort buying or selling was filed on the name this quarter. Cohort Conviction Score: 26 — ranked #502 of 724 scored stocks.

Share𝕏 in

Why super-investors own SUPN

Interest in SUPN within this cohort is minimal and static: just two managers hold the stock, with no additions, trims, or exits recorded in 2026Q1 — a pattern consistent across all eight quarters of available data, during which cohort count held at one before a second owner appeared. Joel Greenblatt accounts for the bulk of the $85M combined position at $77M, though at just 0.1% of his portfolio it is a negligible allocation for him. Third Avenue Management holds a more meaningful 1.3% weighting on a much smaller $8M position, suggesting higher relative conviction. There is no sign of broadening interest among the wider cohort, and the complete absence of activity this quarter indicates neither accumulation nor distribution.

AI-synthesized from 13F filings. Not investment advice.